ONCOLOGÍA CELULAR
![Foto de ONCOLOGÍA CELULAR](/img/grupo.png)
![Foto de Hospital Vall d'Hebron](/img/noimage_org.png)
Hospital Vall d'Hebron
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital Vall d'Hebron (9)
2023
-
Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration
Human Pathology, Vol. 139, pp. 37-46
-
OSNA Total Tumor Load for the Prediction of Axillary Involvement in Breast Cancer Patients: Should We use Different Thresholds According to the Intrinsic Molecular Subtype? MOTTO Study
Clinical Pathology, Vol. 16
2022
-
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
2021
-
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion
Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218
2019
-
Predictive model of breast cancer metastasis in axillary non-sentinel lymph nodes. Emergent variables. The MOTTO study, part I
Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 4, pp. 127-132
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
-
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene, Vol. 36, Núm. 19, pp. 2737-2749
2016
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
-
Stratification and therapeutic potential of PML in metastatic breast cancer
Nature Communications, Vol. 7